Showing 581 - 600 results of 800 for search '"Hepatocellular carcinoma"', query time: 0.04s Refine Results
  1. 581

    Research Progress on the Mechanism of Acupuncture Treatment for Nonalcoholic Fatty Liver Disease by Bai Li, Li Fang

    Published 2022-01-01
    “…Nonalcoholic fatty liver disease (NAFLD) represents the most common chronic liver disease worldwide, ranging from simple steatosis and nonalcoholic steatohepatitis to fibrosis, cirrhosis, and hepatocellular carcinoma. Acupuncture is a long-established treatment in traditional Chinese medicine. …”
    Get full text
    Article
  2. 582

    Forgettable in the care of liver cirrhosis: the unseen culprits of progression from bad to worse by Maha Elsabaawy, Omkosoum Alhaddad

    Published 2024-03-01
    “…The lack of disease-specific nutritional guidance, the prevalent sedentary lifestyle among patients, and insufficient screening for hepatocellular carcinoma, oesophageal varices, sarcopaenia, minimal hepatic encephalopathy, and diabetes mellitus, along with fibrosis progression and cirrhosis decompensation, can add further complexities. …”
    Get full text
    Article
  3. 583

    NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis by Shin Maeda

    Published 2010-01-01
    “…Hepatocellular carcinoma (HCC) is the third largest cause of cancer deaths worldwide. …”
    Get full text
    Article
  4. 584

    Diagnostics of hepatocellular cancer: state-of-the-art by T. Yu. Danzanova, G. T. Sinyukova, P. I. Lepedatu

    Published 2014-10-01
    “…To present features of hepatocellular carcinoma (HCC) diagnostics.Key points. Factors of HCC development, principles of screening diagnostics in risk group are discussed. …”
    Get full text
    Article
  5. 585
  6. 586

    The Role of Eosinophils in Liver DiseaseSummary by Linxi Xie, Hejiao Zhang, Long Xu

    Published 2025-01-01
    “…Although eosinophils are infrequently observed within the liver during periods of homeostasis, they are recruited to the liver in various liver diseases, including liver parasitosis, acute liver injury, autoimmune liver disease, and hepatocellular carcinoma. Furthermore, eosinophils have demonstrated the capacity to promote liver regeneration. …”
    Get full text
    Article
  7. 587

    One-Pot Synthesis of Novel Furochromone and Oxazocine Derivatives as Promising Antitumor Agents with Their Molecular Docking Studies by Rita M. Borik

    Published 2020-01-01
    “…The obtained derivatives of novel furochromone and oxazocine derivatives were evaluated as promising antitumor agents against panel of two human cell lines, hepatocellular carcinoma (HEPG2) and breast carcinoma (MCF7). …”
    Get full text
    Article
  8. 588

    Surviving Emphysematous Gastritis after Hepatectomy by Harry Hok Yee Yu, Simon Tsang, Tan To Cheung, Chung Mau Lo

    Published 2013-01-01
    “…We are reporting a middle-aged Chinese male with hepatitis B virus related hepatocellular carcinoma. He underwent partial hepatectomy and was diagnosed with emphysematous gastritis 4 days after index operation. …”
    Get full text
    Article
  9. 589

    Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC by Yulong Wei, Qingzhu Song, Fenglan Zhang, Tian Yuan

    Published 2021-01-01
    “…Hepatocellular carcinoma (HCC) is one of the primary types of cancer that claims many lives worldwide, and its incidence continues to increase. …”
    Get full text
    Article
  10. 590

    Disruption of tumor-intrinsic PGAM5 increases anti-PD-1 efficacy through the CCL2 signaling pathway by Yan Li, Hong Wang, Xiaoyang Li, Yuan He, Huiquan Liu, Dong Han, Ting Mei, Yixuan Li, Zilong Xu, Xiaoying Wei, Jianguo Wang, Peijie Zhou, Yuwen Wang, Ziye Li, Junhao Ning, Anlin Wang, Jingjing Cheng, Dong Qian

    Published 2025-01-01
    “…Background Immunosuppressive phenotype compromised immunotherapy efficacy of hepatocellular carcinoma. Tumor cells intrinsic mitochondria dynamics could pass effects on the extracellular microenvironment through mtDNA stress. …”
    Get full text
    Article
  11. 591
  12. 592

    Increased Porphyrins in Primary Liver Cancer Mainly Reflect a Parallel Liver Disease by Jerzy Kaczynski, Göran Hansson, Sven Wallerstedt

    Published 2009-01-01
    “…To evaluate the role of an underlying liver disorder we analyzed porphyrins in patients with hepatocellular carcinoma (HCC) (n=65), cholangiocellular carcinoma (n=3), or suspected PLC, which turned out to be metastases (n=18) or a benign disorder (n=11). …”
    Get full text
    Article
  13. 593

    Fibrolamellar Carcinoma: 2012 Update by Michael Torbenson

    Published 2012-01-01
    “…Fibrolamellar carcinomas are not indolent tumors, but have an overall better prognosis than typical hepatocellular carcinomas, in part because of the younger age at presentation and the lack of cirrhosis. …”
    Get full text
    Article
  14. 594

    Recent Advances in Antiviral Therapy for Chronic Hepatitis C by Akihiro Tamori, Masaru Enomoto, Norifumi Kawada

    Published 2016-01-01
    “…Chronic infection induces continuous inflammation in the liver, progression of hepatic fibrosis, eventual cirrhosis, and possible hepatocellular carcinoma. Eradication of the virus is one of the most important treatment aims. …”
    Get full text
    Article
  15. 595

    Autoimmune hepatitis with abnormally high level of serum alpha-fetoprotein (Clinical case) by A. O. Bueverov, Ye. S. Dolmagambetova

    Published 2010-02-01
    “…Manifestations of AIH, at first glance were typical, accompanied by over 200-fold elevation of serum concentration of AFP that required differential diagnostics with hepatocellular carcinoma. Achievement of immunosuppressor-induced remission resulted in normalization of AFP level.Conclusion. …”
    Get full text
    Article
  16. 596

    Oxidative stress in viral hepatitis by Huseyin Erdal, Hacer Ozlem Kalayci

    Published 2024-04-01
    “…This damage manifests as lipid peroxidation, DNA damage, and protein oxidation, which in turn promote hepatic inflammation, fibrosis, and hepatocellular carcinoma. Furthermore, OS has been implicated in the resistance to antiviral therapy observed in some patients. …”
    Get full text
    Article
  17. 597

    Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus by Lung-Wen Tsai, Yi-Hsiang Lu, Rajni Dubey, Jeng-Fong Chiou

    Published 2021-01-01
    “…Clinically, it has also been revealed that the existence of nonalcoholic fatty liver disease (NAFLD) enhances the incidence of type 2 diabetes mellitus (T2DM), while T2DM exacerbates NAFLD to extremely severe forms of steatohepatitis, cirrhosis, and hepatocellular carcinoma. This implies the coexistence and bidirectional nature of NAFLD and T2DM, which function synergistically to drive adverse consequences in clinical practice. …”
    Get full text
    Article
  18. 598

    Sorafenib-Induced Liver Failure: A Case Report and Review of the Literature by Anneleen Van Hootegem, Chris Verslype, Werner Van Steenbergen

    Published 2011-01-01
    “…In patients with hepatocellular carcinoma characterized by vascular invasion and/or extrahepatic disease, Sorafenib is considered treatment of choice. …”
    Get full text
    Article
  19. 599

    Motion – The Available Treatments for Hepatitis C Are Cost Effective: Arguments against the Motion by W Ray Kim

    Published 2002-01-01
    “…Available cohortbased studies suggest that only a relative minority of patients develop significant liver disease, such as cirrhosis and/or hepatocellular carcinoma. Other studies, mostly conducted based on referral patients with established disease, portray much more serious consequences of HCV infection. …”
    Get full text
    Article
  20. 600

    Transitioning to Highly Effective Therapies for the Treatment of Chronic Hepatitis C Virus Infection: A Policy Statement and Implementation Guideline by Daniel J Smyth, Duncan Webster, Lisa Barrett, Mark MacMillan, Lisa McKnight, Frank Schweiger

    Published 2014-01-01
    “…Chronic hepatitis C virus (HCV) infection increases all-cause mortality, rates of cirrhosis, hepatocellular carcinoma, liver transplantation and overall health care utilization. …”
    Get full text
    Article